- Report
- July 2025
- 350 Pages
Global
From €4404EUR$4,949USD£3,877GBP
- Report
- July 2025
- 350 Pages
Global
From €4404EUR$4,949USD£3,877GBP
- Report
- July 2025
- 350 Pages
Global
From €4404EUR$4,949USD£3,877GBP
- Report
- June 2025
- 400 Pages
Global
From €4404EUR$4,949USD£3,877GBP
- Report
- September 2025
- 240 Pages
Global
From €4445EUR$4,995USD£3,913GBP
- Report
- July 2025
- 271 Pages
Global
From €4445EUR$4,995USD£3,913GBP
- Report
- September 2025
- 150 Pages
Global
From €3426EUR$3,850USD£3,016GBP
- Report
- September 2025
- 150 Pages
Global
From €3426EUR$3,850USD£3,016GBP
- Report
- December 2024
Global
From €6674EUR$7,500USD£5,875GBP
- Report
- July 2025
- 132 Pages
Global
From €3668EUR$4,123USD£3,229GBP
€4316EUR$4,850USD£3,799GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2536EUR$2,850USD£2,232GBP
- Report
- June 2025
- 137 Pages
United States
From €5295EUR$5,950USD£4,661GBP
- Report
- September 2025
- 200 Pages
North America
From €2216EUR$2,490USD£1,950GBP
- Report
- May 2025
- 200 Pages
Europe
From €2216EUR$2,490USD£1,950GBP
- Report
- January 2025
- 135 Pages
United States
From €2216EUR$2,490USD£1,950GBP
- Report
- June 2025
- 250 Pages
United States
From €2482EUR$2,789USD£2,185GBP
- Report
- September 2025
- 472 Pages
Asia Pacific
From €5335EUR$5,995USD£4,696GBP
- Report
- September 2025
- 95 Pages
North America
From €2458EUR$2,763USD£2,164GBP
€2892EUR$3,250USD£2,546GBP
- Report
- September 2024
- 188 Pages
Global
From €4270EUR$4,799USD£3,759GBP
- Report
- August 2023
- 1500 Pages
Global
From €7786EUR$8,750USD£6,854GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more